Clinical Trial Update: CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children [Phase 2]

View source ↗

Summary

This Clinical Trial Update describes a Phase 2 study of CANnabinoids for drug-resistant epilepsy in adults and children, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: University of Manitoba | Conditions: Drug Resistant Epilepsy | Phase 2 | Status: NOT_YET_RECRUITING